Clinical Trials Logo

Filter by:
NCT ID: NCT00868725 Completed - Clinical trials for Carcinoma, Squamous Cell

Detecting Lesions in the Oral Cavity With Thermal Imaging

Start date: April 2009
Phase: N/A
Study type: Observational

Previous studies indicate that there are significant differences in the temperature of tumors and normal, adjacent tissues. The present study will test this hypothesis for lesions in the oral cavity. Thermal images of the oral cavities of patients, undergoing examination in the Department of Oral and Maxillofacial Surgery of Sheba hospital, will be compared to the diagnoses of the examining doctors. The results, apart from enhancing the delineation of oral cavity tumors, may help the decision to develop miniature thermal cameras to scan thermally, the GI tract.

NCT ID: NCT00868504 Recruiting - Clinical trials for Carcinoma, Undifferentiated

Measuring Temperatures of Tissues During Endoscopy

Start date: April 2009
Phase: N/A
Study type: Observational

Previous studies have indicated that tumors are warmer than the surrounding tissues. We want to ascertain that this is true for tumors in the GI tract. If so, a thermal camera in an endoscope may aid the diagnosis of tumors. The experiment entails inserting a cannula sheathed thermocouple into the work canal of an endoscope or a colonoscope. The examining physician will bring the distal end to touch the tumors he finds and their adjacent tissues, noting their respective temperatures. This experiment must be conducted before embarking on the complicated and costly project of producing a tiny thermal camera which will be able to navigate the GI tract.

NCT ID: NCT00868478 Recruiting - Clinical trials for Chronic Lymphocytic Leukemia

The Humanized Monoclonal Antibody Milatuzumab for Refractory Chronic Lymphocytic Leukemia (CLL)

Start date: April 2009
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine whether Milatuzumab is effective in patients with refractory chronic lymphocytic leukemia, and also to find out in which range of doses is a response seen.

NCT ID: NCT00868270 Not yet recruiting - Clinical trials for Kidney Scarring Post-Febrile UTI

Urinary Cytokine Levels as a Prognostic Marker for Kidney Scarring After Pyelonephritis

Start date: May 2009
Phase: N/A
Study type: Observational

The prevalence of kidney scarring after UTI is approximately 5-57%. UTIs are caused mainly by bacteria that cause local and systemic immunological reaction that are accompanied by cytokines. These cytokines are a main factor in the inflammatory process. They are produced by leukocytes, macrophages, fibroblasts, endothelial cells and epithelial cells in the kidney tissue. Interleukin 6 and 8 (IL-6 IL-8) were found in high levels in the urine of children and adults who suffer from UTIs. Other studies on animals have found a relationship between inflammatory reaction and scarring in the kidney. We hypothesize that we will find a similar relationship between the level of IL-6, IL-8 in the urine during acute pyelonephritis in children and the probability of kidney scarring.

NCT ID: NCT00867971 Active, not recruiting - Glaucoma Clinical Trials

Is Recombinant Growth Hormone Therapy Associated With Increased Intraoccular Pressure?

Start date: February 2009
Phase: N/A
Study type: Observational

Recombinant growth hormone is a common therapy in the pediatric population. A number of associated side effects have been described. Several years ago, a case report was published concerning a child that was treated with RGH and developed acute glaucoma. To date no study has evaluated the connection.

NCT ID: NCT00867958 Completed - Colorectal Surgery Clinical Trials

Compression Anastomosis Using the CAR™ 27

Start date: September 2008
Phase: N/A
Study type: Interventional

Purpose: Evaluation of the CAR™ 27 for the creation of compression anastomoses. Indication: Compression Anastomosis Ring (CAR™ 27) device for creation of circular anastomoses during colonic or colorectal resection. Study Design: Prospective, open labeled study. Patient Population: Male or female subjects 18 years of age or older who are scheduled for non emergency laparoscopic or open colonic or colorectal resections. A temporary loop ileostomy/colostomy can be preformed up to the discretion of the surgeon. No. of Subjects: 15 patients estimated up to three months to enroll. Duration of Treatment: During the operation - creation of the anastomosis. Duration of Follow-up: Follow-up evaluation will be performed daily while hospitalized, during a post-op clinic visit at approximately 1 month (30 days ± 5 days) including a proctoscopic exam and by phone after 3 months. Endpoints: To evaluate the creation of a safe and functioning anastomosis and the occurrence of adverse events related to the use of the CAR™ 27 device.

NCT ID: NCT00867724 Completed - Rectal Cancer Clinical Trials

Clinical Study-evaluate Performance&Safety "Aer-O-Scope" in Colon of Low Risk Patients

Start date: September 2009
Phase: N/A
Study type: Interventional

A double center study to evaluate the safety and efficacy of the Aer-O-Scope in traveling through the colon in low risk subjects.

NCT ID: NCT00867607 Completed - Clinical trials for Allergic Contact Dermatitis

Safety, Tolerability, and Efficacy of 21 Days Dermal Application of MRX-6 on Mild to Moderate Contact Dermatitis

Start date: March 2011
Phase: Phase 1/Phase 2
Study type: Interventional

A Double-blind, Vehicle-controlled Study to Assess the Safety, Tolerability, and Efficacy of Three Weeks of Daily Dermal Application of MRX-6 or steroid on the Treatment of Mild to Moderate Allergic Contact Dermatitis of the Hand and Forearm. Total number of patients: up to 80.

NCT ID: NCT00867594 Completed - Clinical trials for Brittle Type I Diabetes Mellitus

Effectiveness of Oral Insulin in Unstable Type 1 Diabetes Patients

Start date: July 2008
Phase: Phase 2
Study type: Interventional

The intent of the proposed study is to assess the potential of oral insulin to mitigate diabetic instability and reduce the frequency and severity of hypoglycemic episodes in patients with type 1 diabetes. Restoring hepatic glycogen stores is critical for the normalization of counter-regulation to hypoglycemia in these patients. Oral insulin can provide a means to increase portal insulin levels, shift the ratio of insulin/glucagon in favor of glycogenesis while sparing the patient the risk of hypoglycemia due to peripheral hyperinsulinemia

NCT ID: NCT00867542 Not yet recruiting - Dental Caries Clinical Trials

Dental and Oral Finding in Israeli Children With Past Intrauterine Growth Retardation (IUGR)

Start date: June 2009
Phase: N/A
Study type: Observational

oral status and early childhood caries (ecc) in israeli children with past IUGR